NCT07089823View on ClinicalTrials.gov

A Study of YP05002 in Healthy Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

76

Participants

Timeline

Start Date

August 19, 2025

Primary Completion Date

April 12, 2026

Study Completion Date

June 30, 2026

Conditions

Weight Management

Interventions

DRUG

YP05002

Tablet, QD

OTHER

Placebo

Tablet, QD

Trial Locations (1)

3004

RECRUITING

Nucleus Network Melbourne Clinic, Melbourne

All Listed Sponsors

lead

Yaopharma Co., Ltd.

INDUSTRY